ERBB2 and breast cancer: For instance, mice lacking cyclin D1 or CDK4, as well as mice expressing mutant cyclin D1 (incapable of activating CDK4/6) were resistant to breast cancer induced by the Erbb2/HER2 oncogene [34,63,64].